Innovative radiotherapy offers a precision treatment alternative.

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.